Cardiac troponin in ischemic cardiomyocytes: intracellular decrease before onset of cell death.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.yexmp.2014.02.012PMID 24607416
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Posttranslational modifications of cardiac troponin T: an overview.

  2013cited by this paper
• The Importance of Autophagy in Cardioprotection

  2013cited by this paper
• Time-dependent degradation pattern of cardiac troponin T following myocardial infarction.

  2013cited by this paper
• Requirement for distinct vesicle-associated membrane proteins in insulin- and AMP-activated protein kinase (AMPK)-induced translocation of GLUT4 and CD36 in cultured cardiomyocytes

  2010cited by this paper
• Cardiac Biomarkers In Clinical Practice

  2009cited by this paper
• Reference population and marathon runner sera assessed by highly sensitive cardiac troponin T and commercial cardiac troponin T and I assays.

  2009cited by this paper
• Increases of cardiac troponin in conditions other than acute coronary syndrome and heart failure.

  2009cited by this paper
• Myofilament incorporation determines the stoichiometry of troponin I in transgenic expression and the rescue of a null mutation.

  2009cited by this paper
• Calpain mediates cardiac troponin degradation and contractile dysfunction in atrial fibrillation.

  2008cited by this paper
• Cardiac Troponin T Release after Prolonged Strenuous Exercise

  2008cited by this paper
• Release kinetics of intact and degraded troponin I and T after irreversible cell damage.

  2008cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Utilization of Biochemical Markers in Heart Failure: Preamble

  2007influential reference
• Cardiac troponin increases among runners in the Boston Marathon.

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• The influence of exercise upon cardiac biomarkers: a practical guide for clinicians and scientists.

  2007cited by this paper
• Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation

  2007cited by this paper
• National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical characteristics and utilization of biochemical markers in acute coronary syndromes.

  2007cited by this paper
• Effect of competitive marathon cycling on plasma N-terminal pro-brain natriuretic peptide and cardiac troponin T in healthy recreational cyclists.

  2005cited by this paper
• MURF-1 and MURF-2 target a specific subset of myofibrillar proteins redundantly: towards understanding MURF-dependent muscle ubiquitination.

  2005cited by this paper
• Ventricular Myocyte Caspases Are Directly Responsible for Endotoxin-Induced Cardiac Dysfunction

  2005cited by this paper
• Calpain-1-sensitive myofibrillar proteins of the human myocardium

  2005cited by this paper
• Regulation of cardiac contractile function by troponin I phosphorylation.

  2005cited by this paper
• Partial and delayed release of troponin-I compared with the release of lactate dehydrogenase from necrotic cardiomyocytes

  2004cited by this paper
• Cardiac physiology at the cellular level: use of cultured HL-1 cardiomyocytes for studies of cardiac muscle cell structure and function.

  2004cited by this paper
• Muscle-specific RING finger 1 is a bona fide ubiquitin ligase that degrades cardiac troponin I

  2004cited by this paper
• HL-1 myocytes exhibit PKC and K(ATP) channel-dependent delta opioid preconditioning.

  2003cited by this paper
• Functional consequences of caspase activation in cardiac myocytes

  2002cited by this paper
• Effect of the "Race Across The Alps" in elite cyclists on plasma cardiac troponins I and T.

  2002cited by this paper
• Cardiac troponin elevations in patients without acute coronary syndrome.

  2002cited by this paper
• Calpain-mediated proteolytic cleavage of troponin I induced by hypoxia or metabolic inhibition in cultured neonatal cardiomyocytes

  2000cited by this paper
• HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte.

  1998cited by this paper
• Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. American Association for Clinical Chemistry Subcommittee on cTnI Standardization.

  1998cited by this paper
• Troponin T: genetics, properties and function

  1998cited by this paper
• Different intracellular compartmentations of cardiac troponins and myosin heavy chains: a causal connection to their different early release after myocardial damage.

  1998cited by this paper
• Troponin T or troponin I or CK-MB (or none?).

  1998cited by this paper
• Cardiac Troponin T Release into Plasma after Acute Myocardial Infarction: Only Fractional Recovery Compared with Enzymes

  1996cited by this paper
• Intracellular compartmentation of troponin T: release kinetics after global ischemia and calcium paradox in the isolated perfused rat heart.

  1995cited by this paper
• Intracellular compartmentation of cardiac troponin T and its release kinetics in patients with reperfused and nonreperfused myocardial infarction.

  1991cited by this paper
• Ca2+ sensitivity change and troponin loss in cardiac natural actomyosin after coronary occlusion.

  1981cited by this paper

• Identification and validation of hypoxia-responsive signature pathways in human cardiomyocytes

  2025cites this paper
• Saudi Heart Association Position Statement on Troponin use for Cardiovascular Risk Screening in Asymptomatic Populations

  2025cites this paper
• Vascularized and Perfusable Human Heart‐on‐a‐Chip Model Recapitulates Aspects of Myocardial Ischemia and Enables Analysis of Nanomedicine Delivery

  2025cites this paper
• The Pathophysiology of Cardiac Troponin Release and the Various Circulating Cardiac Troponin Forms—Potential Clinical Implications

  2025cites this paper
• Understanding the circulating forms of cardiac troponin: insights for clinical practice

  2025cites this paper
• Cardiac troponin complexes and fragments: potential targets for improved clinical performance

  2025cites this paper
• Engineered exosomes: a potential therapeutic strategy for septic cardiomyopathy

  2024cites this paper
• Pericardial fluid troponin in cardiac surgery.

  2024cites this paper
• Cardioprotective Effects of Dexmedetomidine in an Oxidative-Stress In Vitro Model of Neonatal Rat Cardiomyocytes

  2023cites this paper
• Closer to The Heart: Harnessing the Power of Targeted Extracellular Vesicle Therapies

  2023cites this paper
• Kinetics of cardiac troponin and other biomarkers in patients with ST elevation myocardial infarction

  2023cites this paper
• Extracellular Histone-Induced Protein Kinase C Alpha Activation and Troponin Phosphorylation Is a Potential Mechanism of Cardiac Contractility Depression in Sepsis

  2023cites this paper
• Current understanding of cardiac troponins metabolism: a narrative review.

  2022cites this paper
• The Metabolic Pathway of Cardiac Troponins Release: Mechanisms and Diagnostic Role

  2022cites this paper
• Features of the Metabolisms of Cardiac Troponin Molecules—Part 1: The Main Stages of Metabolism, Release Stage

  2022cites this paper
• [Morphopathology of myocardial hypoxic-ischemic injuries in newborns at 22-27 weeks' gestation].

  2021cites this paper
• Trauma, a Matter of the Heart—Molecular Mechanism of Post-Traumatic Cardiac Dysfunction

  2021cites this paper
• Secretome Analysis of Cardiomyocytes Identifies PCSK6 (Proprotein Convertase Subtilisin/Kexin Type 6) as a Novel Player in Cardiac Remodeling After Myocardial Infarction

  2020cites this paper
• Cardiac Troponin Composition Characterization after Non ST-Elevation Myocardial Infarction: Relation with Culprit Artery, Ischemic Time Window, and Severity of Injury.

  2020cites this paper
• Opportunities for microRNAs in the Crowded Field of Cardiovascular Biomarkers.

  2019cites this paper
• A human in vitro platform for the evaluation of pharmacology strategies in cardiac ischemia

  2019cites this paper
• Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure.

  2019cites this paper
• Hypoxia-elicited mesenchymal stem cell-derived exosomes facilitates cardiac repair through miR-125b-mediated prevention of cell death in myocardial infarction

  2018cites this paper
• What's Next for Acute Heart Failure Research?

  2018cites this paper
• Increased constitutive nitric oxide production by whole body periodic acceleration ameliorates alterations in cardiomyocytes associated with utrophin/dystrophin deficiency.

  2017cites this paper
• The 99th percentile of reference population for cTnI and cTnT assay: methodology, pathophysiology and clinical implications

  2017cites this paper
• Cardiac Troponin T: Smaller Molecules in Patients with End-Stage Renal Disease than after Onset of Acute Myocardial Infarction.

  2017cites this paper
• Identification and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction.

  2017cites this paper
• Development of a targeted selected ion monitoring assay for the elucidation of protease induced structural changes in cardiac troponin T.

  2016cites this paper
• Cardiac troponin T degradation in serum is catalysed by human thrombin.

  2016cites this paper
• Modified VEGF targets the ischemic myocardium and promotes functional recovery after myocardial infarction.

  2015cites this paper
• Alteração de biomarcadores de lesão miocárdica em atletas após a Maratona Internacional de São Paulo

  2015cites this paper
• Patterns and determinants of temporal change in high-sensitivity cardiac troponin-T: The Atherosclerosis Risk in Communities Cohort Study.

  2015cites this paper
• High-sensitivity cardiac troponins in heart and kidney diseases: from lab to clinic

  2015cites this paper
• Identification and and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction

  year unknowncites this paper
• Identification and and Characterization of Cardiac Troponin T Fragments in Serum of Patients Suffering from Acute Myocardial Infarction

  year unknowncites this paper